hiPSC来源心脏细胞分泌的外泌体改善猪心肌梗死恢复
该研究在猪心肌梗死模型中比较了注射hiPSC来源的心肌细胞、内皮细胞和平滑肌细胞混合物,或从这三种细胞中提取的外泌体对心肌恢复的疗效。结果显示,细胞治疗、细胞匀浆碎片和外泌体治疗组在梗死4周后的左室射血分数、室壁应力、心肌生物能量学、心肌肥厚、瘢痕大小、细胞凋亡和血管新生等方面均优于未治疗组,且外泌体治疗未增加心律失常事件频率。
要点
- hiPSC来源心脏细胞分泌的外泌体可改善猪心肌梗死后的心肌恢复。
- 外泌体治疗在改善心功能、减少瘢痕和凋亡、促进血管新生方面与细胞治疗相当。
- 外泌体治疗未增加心律失常事件频率,可能成为无细胞治疗选择。
核心结论
- hiPSC来源心脏细胞分泌的外泌体可改善猪心肌梗死后的心肌恢复,且不增加心律失常并发症频率,可能为心肌损伤提供无细胞治疗选择。
主要发现
- 体外实验中,外泌体促进内皮细胞管腔形成和小鼠主动脉环微血管发芽,并通过减少凋亡、维持细胞内钙稳态和增加三磷酸腺苷保护hiPSC心肌细胞。
- 体内实验中,梗死4周后,细胞治疗组、匀浆碎片组和外泌体组的左室射血分数、室壁应力、心肌生物能量学、心肌肥厚、瘢痕大小、细胞凋亡和梗死区血管新生均优于仅心肌梗死组。
- 仅心肌梗死组、细胞治疗组和外泌体组的心律失常事件频率相似。
临床怎么用
- 外泌体可能作为无细胞治疗选择用于心肌损伤,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cell therapy treatment of myocardial infarction (MI) is mediated, in part, by exosomes secreted from transplanted cells. Thus, we compared the efficacy of treatment with a mixture of cardiomyocytes (CMs; 10 million), endothelial cells (ECs; 5 million), and smooth muscle cells (SMCs; 5 million) derived from human induced pluripotent stem cells (hiPSCs), or with exosomes extracted from the three cell types, in pigs after MI. Female pigs received sham surgery; infarction without treatment (MI group); or infarction and treatment with hiPSC-CMs, hiPSC-ECs, and hiPSC-SMCs (MI + Cell group); with homogenized fragments from the same dose of cells administered to the MI + Cell group (MI + Fra group); or with exosomes (7.5 mg) extracted from a 2:1:1 mixture of hiPSC-CMs:hiPSC-ECs:hiPSC-SMCs (MI + Exo group). Cells and exosomes were injected into the injured myocardium. In vitro, exosomes promoted EC tube formation and microvessel sprouting from mouse aortic rings and protected hiPSC-CMs by reducing apoptosis, maintaining intracellular calcium homeostasis, and increasing adenosine 5'-triphosphate. In vivo, measurements of left ventricular ejection fraction, wall stress, myocardial bioenergetics, cardiac hypertrophy, scar size, cell apoptosis, and angiogenesis in the infarcted region were better in the MI + Cell, MI + Fra, and MI + Exo groups than in the MI group 4 weeks after infarction. The frequencies of arrhythmic events in animals from the MI, MI + Cell, and MI + Exo groups were similar. Thus, exosomes secreted by hiPSC-derived cardiac cells improved myocardial recovery without increasing the frequency of arrhythmogenic complications and may provide an acellular therapeutic option for myocardial injury.
引用
- Gao L, Wang L, Wei Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med. 2020. PMID: 32938792. doi:10.1126/scitranslmed.aay1318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。